Effects of a human amniotic membrane extract on ARPE-19 cells.
ARPE-19
Apoptosis
EMT
Human amniotic membrane
PVR
Retina
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
14 Jun 2024
14 Jun 2024
Historique:
received:
10
08
2023
accepted:
16
05
2024
medline:
14
6
2024
pubmed:
14
6
2024
entrez:
14
6
2024
Statut:
epublish
Résumé
Human Amniotic Membrane (hAM) is endowed with several biological activities and might be considered an optimal tool in surgical treatment for different ophthalmic pathologies. We pioneered the surgical use of hAM to treat retinal pathologies such as macular holes, tears, and retinal detachments, and to overcome photoreceptor damage in age-related macular degeneration. Although hAM contributed to improved outcomes, the mechanisms of its effects are not yet fully understood. The characterization and explanation of the effects of hAM would allow the adoption of this new natural product in different retinal pathologies, operative contexts, and hAM formulations. At this end, we studied the properties of a hAM extract (hAME) on the ARPE-19 cells. A non-denaturing sonication-based technique was developed to obtain a suitable hAME. Viability, proliferation, apoptosis, oxidative stress, and epithelial-mesenchymal transition (EMT) were studied in hAME-treated ARPE-19 cells. The hAME was able to increase ARPE-19 cell viability even in the presence of oxidative stress (H Our results demonstrate that the hAME retains most of the properties observed in the whole tissue by others. The hAME, other than providing a manageable research tool, could represent a cost-effective and abundant drug to treat retinal pathologies in the future.
Sections du résumé
BACKGROUND
BACKGROUND
Human Amniotic Membrane (hAM) is endowed with several biological activities and might be considered an optimal tool in surgical treatment for different ophthalmic pathologies. We pioneered the surgical use of hAM to treat retinal pathologies such as macular holes, tears, and retinal detachments, and to overcome photoreceptor damage in age-related macular degeneration. Although hAM contributed to improved outcomes, the mechanisms of its effects are not yet fully understood. The characterization and explanation of the effects of hAM would allow the adoption of this new natural product in different retinal pathologies, operative contexts, and hAM formulations. At this end, we studied the properties of a hAM extract (hAME) on the ARPE-19 cells.
METHODS AND RESULTS
RESULTS
A non-denaturing sonication-based technique was developed to obtain a suitable hAME. Viability, proliferation, apoptosis, oxidative stress, and epithelial-mesenchymal transition (EMT) were studied in hAME-treated ARPE-19 cells. The hAME was able to increase ARPE-19 cell viability even in the presence of oxidative stress (H
CONCLUSIONS
CONCLUSIONS
Our results demonstrate that the hAME retains most of the properties observed in the whole tissue by others. The hAME, other than providing a manageable research tool, could represent a cost-effective and abundant drug to treat retinal pathologies in the future.
Identifiants
pubmed: 38874663
doi: 10.1007/s11033-024-09647-7
pii: 10.1007/s11033-024-09647-7
doi:
Substances chimiques
Tissue Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
746Informations de copyright
© 2024. The Author(s).
Références
Roy A, Mantay M, Brannan C et al (2022) Placental tissues as biomaterials in regenerative medicine. Biomed Res Int 2022:6751456. https://doi.org/10.1155/2022/6751456
doi: 10.1155/2022/6751456
pubmed: 35496035
pmcid: 9050314
Samarkanova D, Cox S, Hernandez D et al (2021) Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties. Sci Rep 11:13754. https://doi.org/10.1038/s41598-021-93150-7
doi: 10.1038/s41598-021-93150-7
pubmed: 34215804
pmcid: 8253755
de Rötth A (1940) Plastic repair of conjunctival defects with fetal membranes. Arch Ophthalmol 23:522–525. https://doi.org/10.1001/archopht.1940.00860130586006
doi: 10.1001/archopht.1940.00860130586006
Zhang S, Ye K, Gao G et al (2022) Amniotic membrane enhances the characteristics and function of stem cell-derived retinal pigment epithelium sheets by inhibiting the epithelial-mesenchymal transition. Acta Biomater 151:183–196. https://doi.org/10.1016/j.actbio.2022.07.064
doi: 10.1016/j.actbio.2022.07.064
pubmed: 35933105
Rizzo S, Caporossi T, Tartaro R et al (2019) A human amniotic membrane plug to promote retinal breaks repair and recurrent macular hole closure. Retina 39(Suppl 1):S95–S103. https://doi.org/10.1097/IAE.0000000000002320
doi: 10.1097/IAE.0000000000002320
pubmed: 30312261
Caporossi T, Tartaro R, De Angelis L et al (2019) A human amniotic membrane plug to repair retinal detachment associated with large macular tear. Acta Ophthalmol 97:821–823. https://doi.org/10.1111/aos.14109
doi: 10.1111/aos.14109
pubmed: 30953398
Lakkaraju A, Umapathy A, Tan LX et al (2020) The cell biology of the retinal pigment epithelium. Prog Retin Eye Res 24:100846. https://doi.org/10.1016/j.preteyeres.2020.100846
doi: 10.1016/j.preteyeres.2020.100846
Gelat B, Rathaur P, Malaviya P et al (2022) The intervention of epithelial-mesenchymal transition in homeostasis of human retinal pigment epithelial cells: a review. J Histotechnol 45:148–160. https://doi.org/10.1080/01478885.2022.2137665
doi: 10.1080/01478885.2022.2137665
pubmed: 36377481
Limb GA, Little BC, Meager A et al (1991) Cytokines in proliferative vitreoretinopathy. Eye (Lond) 5 (Pt 6):686 – 93. https://doi.org/10.1038/eye.1991.126
Palomares-Ordóñez JL, Sánchez-Ramos JA, Ramírez-Estudillo JA et al (2019) Correlation of transforming growth factor β-1 vitreous levels with clinical severity of proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Arch Soc Esp Oftalmol (Engl Ed) 94:12–17. https://doi.org/10.1016/j.oftal.2018.08.002
doi: 10.1016/j.oftal.2018.08.002
pubmed: 30309666
Schulz A, Rickmann A, Julich-Haertel H et al (2021) Comparative cytotoxic and antiproliferative profile of methotrexate and fluorouracil on different ocular cells. Acta Ophthalmol 99:e1070–e1076. https://doi.org/10.1111/aos.14735
doi: 10.1111/aos.14735
pubmed: 33381918
Hao Y, Ma DH, Hwang DG et al (2000) Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 19:348–352. https://doi.org/10.1097/00003226-200005000-00018
doi: 10.1097/00003226-200005000-00018
pubmed: 10832697
Mao Y, Jacob V, Singal A et al (2021) Exosomes secreted from amniotic membrane contribute to its anti-fibrotic activity. Int J Mol Sci 22:2055. https://doi.org/10.3390/ijms22042055
He H, Kuriyan AE, Su CW et al (2017) Inhibition of proliferation and epithelial mesenchymal transition in retinal pigment epithelial cells by heavy chain-hyaluronan/pentraxin 3. Sci Rep 7:43736. https://doi.org/10.1038/srep43736
doi: 10.1038/srep43736
pubmed: 28252047
pmcid: 5333089
Hillenmayer A, Wertheimer CM, Gerhard MJ et al (2023) Epiretinal Amniotic Membrane in complicated retinal detachment: a clinical and in Vitro Safety Assessment. Ophthalmol Ther 12:1635–1648. https://doi.org/10.1007/s40123-023-00695
doi: 10.1007/s40123-023-00695
pubmed: 36905569
pmcid: 10164220
Peri S, Biagioni A, Versienti G et al (2021) Enhanced vasculogenic capacity induced by 5-Fluorouracil Chemoresistance in a gastric Cancer cell line. Int J Mol Sci 22:7698. https://doi.org/10.3390/ijms22147698
doi: 10.3390/ijms22147698
pubmed: 34299320
pmcid: 8303918
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675. https://doi.org/10.1038/nmeth.2089
doi: 10.1038/nmeth.2089
pubmed: 22930834
pmcid: 5554542
Takahashi E, Nagano O, Ishimoto T et al (2010) Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. J Biol Chem 285:4060–4073. https://doi.org/10.1074/jbc.M109.056523
doi: 10.1074/jbc.M109.056523
pubmed: 19965872
Lee J, Choi JH, Joo CK (2013) TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin. Cell Death Dis 4:e714. https://doi.org/10.1038/cddis.2013.244
doi: 10.1038/cddis.2013.244
pubmed: 23828577
pmcid: 3730417
Grigoryan EN (2022) Pigment epithelia of the Eye: cell-type Conversion in Regeneration and Disease. Life (Basel) 12:382. https://doi.org/10.3390/life12030382
doi: 10.3390/life12030382
pubmed: 35330132
Salman A, McClements ME, MacLaren RE (2021) Insights on the regeneration potential of Müller glia in the mammalian retina. Cells 10:1957. https://doi.org/10.3390/cells10081957
Grierson I, Hiscott P, Hogg P et al (1994) Development, repair and regeneration of the retinal pigment epithelium. Eye (Lond) 8:255–262. https://doi.org/10.1038/eye.1994.54
doi: 10.1038/eye.1994.54
pubmed: 7525361
Hanovice NJ, Leach LL, Slater K et al (2019) Regeneration of the zebrafish retinal pigment epithelium after widespread genetic ablation. PLoS Genet 15:e1007939. https://doi.org/10.1371/journal.pgen.1007939
doi: 10.1371/journal.pgen.1007939
pubmed: 30695061
pmcid: 6368336
Huang X, Wei Y, Ma H et al (2012) Vitreous-induced cytoskeletal rearrangements via the Rac1 GTPase-dependent signaling pathway in human retinal pigment epithelial cells. Biochem Biophys Res Commun 419:395–400. https://doi.org/10.1016/j.bbrc.2012.02.033
doi: 10.1016/j.bbrc.2012.02.033
pubmed: 22349509
Krishna L, Dhamodaran K, Subramani M et al (2019) Protective role of decellularized human amniotic membrane from oxidative stress-induced damage on retinal pigment epithelial cells. ACS Biomater Sci Eng 5:357–372. https://doi.org/10.1021/acsbiomaterials.8b00769
doi: 10.1021/acsbiomaterials.8b00769
pubmed: 33405878
Robbins SG, Brem RB, Wilson DJ et al (1994) Immunolocalization of integrins in proliferative retinal membranes. Invest Ophthalmol Vis Sci 35:3475–3485
pubmed: 8056523
Cai W, Yu D, Fan J et al (2018) Quercetin inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells via the smad pathway. Drug Des Devel Ther 12:4149–4161. https://doi.org/10.2147/DDDT.S185618
doi: 10.2147/DDDT.S185618
pubmed: 30584279
pmcid: 6287523
Weidinger A, Poženel L, Wolbank S et al (2021) Sub-regional differences of the Human Amniotic Membrane and their potential impact on tissue regeneration application. Front Bioeng Biotechnol 8:613804. https://doi.org/10.3389/fbioe.2020.613804
doi: 10.3389/fbioe.2020.613804
pubmed: 33520964
pmcid: 7839410